Earnings Feed
Start Free
LEVI STRAUSS & CO·4

Feb 3, 5:54 PM ET

Jedrzejek David 4

Research Summary

AI-generated summary

Updated

LEVI SVP/GC David Jedrzejek Receives RSUs, Sells 2,248 Shares

What Happened

  • David Jedrzejek, Senior Vice President and General Counsel of Levi Strauss & Co. (LEVI), was granted RSU awards and completed small share disposals. The filing shows two RSU grants on 2026-01-30 totaling 56,416 RSUs (14,104 + 42,312) granted at $0.00 (these are contingent awards, not open-market purchases).
  • The filing also reports tax-withholding of 3,231 shares on 2026-01-30 (disposed at $19.88 each for $64,232) to cover taxes on a settlement of vested RSUs, plus an open-market sale of 2,248 shares on 2026-02-03 at $19.60 each for $44,061 (pursuant to a previously established Rule 10b5-1 plan).

Key Details

  • Transaction dates and prices:
    • 2026-01-30: RSU grants — 14,104 and 42,312 RSUs (awards, $0.00 per share).
    • 2026-01-30: 3,231 shares withheld for taxes at $19.88 — $64,232.
    • 2026-02-03: Open-market sale of 2,248 shares at $19.60 — $44,061 (10b5-1 plan).
  • Shares owned after the transactions: Not specified in the filing.
  • Notable footnotes:
    • RSUs are contingent rights to receive one share upon settlement; the larger RSU grant vests in four equal installments (25% each) on Jan 29, 2027; Jan 28, 2028; Jan 26, 2029; and Jan 25, 2030, subject to continued service.
    • Shares were withheld to satisfy tax obligations from RSU settlement.
    • The Feb 3 sale was made under a pre-established Rule 10b5-1 plan.
  • Filing timeliness: Form filed 2026-02-03 reporting transactions dated 2026-01-30 and 2026-02-03; filing appears to be within the required Form 4 time frame.

Context

  • RSU grants are compensation awards (not purchases) and vest over multiple years; they do not necessarily signal near-term buying or selling intent. The tax-withholding entry is routine when RSUs are settled.
  • The open-market sale was executed under a 10b5-1 plan (pre-set trading plan), which is commonly used to avoid trading on inside information. Retail investors should view these routine grants and sales as standard executive compensation and liquidity actions, not direct indicators of company outlook.